undamentalytics Newsletter

Owlet vs Xtant Medical Holdings

Xtant Medical Holdings is the larger business, with $134m of revenue in fiscal 2025 against $106m for Owlet (1.3 times as much). Owlet grew faster (37.1% against 14.2%). Xtant Medical Holdings kept more of each dollar of sales as profit: a net margin of 3.7% against -36.6%.

Latest fiscal yearOwletOWLT, 2025Xtant Medical HoldingsXTNT, 2025
Revenue $106m $134m
Revenue growth 37.1% 14.2%
Net income −$38.8m $5.0m
Operating margin — 5.4%
Net margin -36.6% 3.7%
Return on equity — 10.6%
Free cash flow −$11.1m $10.2m
Cash $35.5m $17.1m
Total debt $20.0m $28.4m
Debt to equity — 55.7%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 108 151
Market value $122m $40.6m
Price vs our value range — —
Moat score 25 (Weak) 38 (Weak)
Insider trades, 12 months 0 buys, 6 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.